MiNK Therapeutics (INKT) News Today $0.71 -0.01 (-1.39%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period MiNK Therapeutics Appoints Dr. Robert Kadlec to BoardOctober 31 at 11:50 PM | markets.businessinsider.comMiNK Therapeutics appoints Robert Kadlec to board of directorsOctober 31 at 11:50 PM | markets.businessinsider.comMiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board of DirectorsOctober 31 at 9:15 AM | globenewswire.comCritical Review: MiNK Therapeutics (NASDAQ:INKT) versus Compass Therapeutics (NASDAQ:CMPX)October 25, 2024 | americanbankingnews.comMiNK Therapeutics aandeel stijgt door nieuwe RNA-samenwerking met AutonomousOctober 9, 2024 | nl.investing.comMiNK Therapeutics Inc (INKT) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...October 9, 2024 | finance.yahoo.comMiNK, Autonomous Partner To Develop Novel Therapies Targeting Metastatic TumorsOctober 8, 2024 | markets.businessinsider.comMiNK Therapeutics and Autonomous Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic TumorsOctober 8, 2024 | globenewswire.comMiNK Therapeutics to Present Data From iNKT Cell Programs at SITC 2024October 4, 2024 | globenewswire.comMiNK Therapeutics faces potential Nasdaq delistingSeptember 15, 2024 | investing.comMiNK Therapeutics to Participate in H.C. Wainwright Global Investment ConferenceSeptember 3, 2024 | globenewswire.comMiNK Therapeutics, Inc. (NASDAQ:INKT) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | msn.comWinstgesprek: MiNK Therapeutics rapporteert vooruitgang Q2 2024August 14, 2024 | nl.investing.comMiNK Reports Second Quarter 2024 Results and Business UpdateAugust 13, 2024 | globenewswire.comMiNK Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial ReportAugust 1, 2024 | globenewswire.comMiNK Therapeutics voldoet aan de kapitaalvereisten van NasdaqJuly 31, 2024 | nl.investing.comMiNK Therapeutics Regains Compliance with Nasdaq Capital Market RequirementJuly 31, 2024 | globenewswire.comMiNK Therapeutics Announces Virtual Annual Shareholders MeetingJune 5, 2024 | globenewswire.comMiNK Therapeutics: MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual MeetingMay 22, 2024 | finanznachrichten.deMiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual MeetingMay 22, 2024 | globenewswire.comQ1 2024 Mink Therapeutics Inc Earnings CallMay 15, 2024 | uk.finance.yahoo.comMiNK Therapeutics Inc (INKT) Q1 2024 Earnings Call Transcript Highlights: Strategic Reductions ...May 15, 2024 | finance.yahoo.comINKT Stock Earnings: MiNK Therapeutics Beats EPS for Q1 2024May 14, 2024 | investorplace.comMiNK Reports First Quarter 2024 ResultsMay 14, 2024 | globenewswire.comMiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board ObserverMay 13, 2024 | globenewswire.comMiNK to Provide Corporate Update and First Quarter 2024 Financial ReportApril 30, 2024 | finance.yahoo.comMiNK to Provide Corporate Update and First Quarter 2024 Financial ReportApril 30, 2024 | globenewswire.comThis MiNK Therapeutics Insider Increased Their Holding In The Last YearApril 11, 2024 | finance.yahoo.comMiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACRApril 8, 2024 | globenewswire.comBuy Rating for MiNK Therapeutics Amidst Promising AGENT-797 Progress and Strategic Financial MovesMarch 25, 2024 | markets.businessinsider.comMiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | insidermonkey.comPromising Clinical Progress and Market Potential for MiNK Therapeutics’ agenT-797 in Gastric Cancer StudyMarch 21, 2024 | markets.businessinsider.comINKT Stock Earnings: MiNK Therapeutics Misses EPS for Q4 2023March 21, 2024 | investorplace.comMiNK Reports Fourth Quarter and Year-End 2023 ResultsMarch 21, 2024 | globenewswire.comEarnings Outlook For MiNK TherapeuticsMarch 20, 2024 | benzinga.comMiNK Therapeutics: MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR 2024March 8, 2024 | finanznachrichten.deMiNK to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial ReportMarch 7, 2024 | globenewswire.comMiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR 2024March 6, 2024 | globenewswire.comCell therapy could help patients with ARDS from severe Covid-19, study involving ARU showsFebruary 24, 2024 | msn.comFirst Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allogeneic INKT Cell Therapy and Agenus’ Botensilimab and BalstilimabFebruary 14, 2024 | finance.yahoo.comMiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature CommunicationsFebruary 6, 2024 | finance.yahoo.comMiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in OncogeneJanuary 30, 2024 | finance.yahoo.comImmunoScape, MiNK Therapeutics Join To Develop Next-generation TCR TherapiesDecember 20, 2023 | markets.businessinsider.comImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic DevelopmentDecember 20, 2023 | finance.yahoo.comMiNK Therapeutics Inc INKTNovember 22, 2023 | morningstar.comMiNK Therapeutics GAAP EPS of -$0.15November 9, 2023 | msn.comMiNK Therapeutics Reports Third Quarter 2023 ResultsNovember 9, 2023 | finance.yahoo.comMiNK Therapeutics Inc (INKT) Reports Q3 2023 Results: Clinical Progress Amid Financial ChallengesNovember 9, 2023 | finance.yahoo.comMiNK Therapeutics Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in Solid Tumors at SITC 2023November 3, 2023 | finance.yahoo.comMiNK Therapeutics Insider Ups Holding During YearNovember 3, 2023 | finance.yahoo.com Get MiNK Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for INKT and its competitors with MarketBeat's FREE daily newsletter. Email Address Market "Famine" Coming (Ad)Market Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicted the 2020 crash a month before it happened... For a limited time, he's revealing his latest forecast here. INKT Media Mentions By Week INKT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INKT News Sentiment▼0.000.43▲Average Medical News Sentiment INKT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INKT Articles This Week▼30▲INKT Articles Average Week Get MiNK Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for INKT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Celularity News Today Elevation Oncology News Today Atara Biotherapeutics News Today Precision BioSciences News Today Cellectis News Today PyroGenesis Canada News Today Senti Biosciences News Today Benitec Biopharma News Today AlloVir News Today FibroBiologics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INKT) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiNK Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INKT Stock Alerts